Ceca S.A.
USPTO PatentsView assignee record - 5 granted patents across 9 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus).
The verdict
According to USPTO PatentsView, Ceca ranks #45,520 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 9 technology areas.
- #45,520
- of 49,997 US assignees by volume
- 36th percentile
- by Innovation Score (31.0/100)
- 23.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R45520 · Foreign Corporation #45,520 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #45,520/49,997
- PHOTO-FINISH CCI Holdings
- CPC-NARROW B01J · 9 areas
- INNOV-THIN 31.0/100
- CLAIMS-DENSE 23.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: CCI Holdings Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ceca’s 31.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ceca
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ceca · this assignee 31
Ceca · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ceca's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ceca?
Each dot is one of Ceca’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ceca’s own 23.6 claims/patent is ABOVE the 10.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ceca's grants concentrate
Ceca S.A. is a focused PatentsView assignee: 9 CPC subclasses with 60% of grants classified under B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus). Peak complete grant year is 2015 (3 grants) versus a trough of 2 in 2017. By volume, Ceca sits between CCI Holdings Inc. and Cellblock FCS, LLC.
Who files at Ceca's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- CCI Holdings
CCI Holdings Inc.
5 patents
- CCR
CCR Technologies, Ltd.
5 patents
- CE+T Power Luxemb…
CE+T Power Luxembourg SA
5 patents
- Ceat Specialty Ty…
Ceat Specialty Tyres Limited
5 patents
- Cedes Safety & Au…
Cedes Safety & Automation AG
5 patents
- Cell Therapy AND…
Cell Therapy AND Technology S.A. DE C.V.
5 patents
- Cellact Pharma
Cellact Pharma GMBH
5 patents
- Cellblock FCS
Cellblock FCS, LLC
5 patents
- Ceca ◀
Ceca S.A.
5 patents
What this shows Ceca holds 5 patents at rank #45,468, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ceca
By rank, the assignees closest to #45,468 in granted patent volume.
- CCI Holdings Inc. #45,464 · 5 patents
- CCR Technologies, Ltd. #45,465 · 5 patents
- CE+T Power Luxembourg SA #45,466 · 5 patents
- Ceat Specialty Tyres Limited #45,467 · 5 patents
- Cedes Safety & Automation AG #45,469 · 5 patents
- Cell Therapy AND Technology S.A. DE C.V. #45,470 · 5 patents
- Cellact Pharma GMBH #45,471 · 5 patents
- Cellblock FCS, LLC #45,472 · 5 patents
Leaders in B01J (Chemical OR Physical Processes)
Other assignees with the most granted patents in Ceca's primary technology class.
Ceca's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 36th percentile higher than 36% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 60.0% |
| 2017 | 2 | 40.0% |
Which technologies does Ceca S.A. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ceca S.A.'s patent record in context - here's where to go next.
- Ceca S.A.'s lead technology class is B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus), 60% of its portfolio - see every assignee active in that class. Explore B01J
- Ranked #45,520 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ceca S.A. against CCI Holdings Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.